Biovac to manufacture pneumococcal vaccine

The ANC welcomes the official launch of a significant public-private partnership between global pharmaceutical giant, Pfizer, and the Biovac Institute by the Science and Technology Minister Naledi Pando. This public-private partnership aims to enable local manufacturing of a vaccine against pneumonia-causing bacteria, which will be manufactured at Biovac`s new commercial-scale facility in Cape Town.

The launch of the local manufacture of pneumococcal conjugate vaccine is a stepping stone to the ultimate dream of developing our own vaccines and should be celebrated as it would benefit not only South Africa but the whole Southern African region.

Therefore the ANC believes that this initiative will alleviate South Africa`s continued dependence on imports supply of essential vaccines.

I thank you.